Login / Signup

Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.

Gaëlle TachonUlrich CortesPierre-Olivier GuichetPierre RivetAnais BalbousKonstantin MasliantsevAntoine BergerOdile BoissonnadeMichel WagerLucie Karayan-Tapon
Published in: International journal of molecular sciences (2018)
"Glioma Stem Cells" (GSCs) are known to play a role in glioblastoma (GBM) recurrence. Homologous recombination (HR) defects and cell cycle checkpoint abnormalities can contribute concurrently to the radioresistance of GSCs. DNA repair protein RAD51 homolog 1 (RAD51) is a crucial protein for HR and its inhibition has been shown to sensitize GSCs to irradiation. The aim of this study was to examine the consequences of ionizing radiation (IR) for cell cycle progression in GSCs. In addition, we intended to assess the potential effect of RAD51 inhibition on cell cycle progression. Five radiosensitive GSC lines and five GSC lines that were previously characterized as radioresistant were exposed to 4Gy IR, and cell cycle analysis was done by fluorescence-activated cell sorting (FACS) at 24, 48, 72, and 96 h with or without RAD51 inhibitor. Following 4Gy IR, all GSC lines presented a significant increase in G2 phase at 24 h, which was maintained over 72 h. In the presence of RAD51 inhibitor, radioresistant GSCs showed delayed G2 arrest post-irradiation for up to 48 h. This study demonstrates that all GSCs can promote G2 arrest in response to radiation-induced DNA damage. However, following RAD51 inhibition, the cell cycle checkpoint response differed. This study contributes to the characterization of the radioresistance mechanisms of GSCs, thereby supporting the rationale of targeting RAD51-dependent repair pathways in view of radiosensitizing GSCs.
Keyphrases
  • cell cycle
  • dna repair
  • dna damage
  • cell proliferation
  • stem cells
  • dna damage response
  • radiation induced
  • oxidative stress
  • clinical trial
  • amino acid
  • risk assessment
  • drug delivery
  • quantum dots
  • cancer stem cells